Today is #WorldCCADay ! All together we ´Shine a light on #cholangiocarcinoma' We are committed to do innovative and powerful research that allows the treatment and cure of this liver disease. Join us increasing awareness and patient support Cholangiocarcinoma Foundation EURO-CHOLANGIO-NET ENS-CCA

Día de Andalucía Starter Pack

The Digital Training School on #cholangiocarcinoma models coordinated by chiara braconi and Diego Calvisi starts on Thursday! Trainees will have the chance to learn about the best tools to study CCA from an international panel of experts 🖥️🔬

Day one of the #TrainingSchool is over! The morning session has covered the rationale, limitations, challenges and usefulness of pre-clinical models in the study of cholangiocarcinoma. COST EASLnews ENS-CCA A lot of science, research and education today. Thread👇🏼

The Training School is over! Thanks to the organizers chiara braconi and Diego Calvisi for a fantastic meeting and thanks to everybody who participated. The trainees had the opportunity to learn from the best panel of international experts on CCA. Highlights of Session 2 👇🏼

Finally out! It took us 5 years to understand the impressive phenotype!! Fatty acid oxidation is not always increased in HCC. Thanks to all the group and collaborators!! A nice journey! cancerres.aacrjournals.org/content/81/11/…

Cáncer hepático y metabolismo de lípidos 👨🏻‍🔬🧬💊 👉🏽👉🏽👉🏽 ciberehd.org/noticias/descu…

Un honor recibir este premio hoy en el congreso #SEBBM21 Gracias a la SEBBM y a la FEBS Letters por reconocer e impulsar el trabajo de los jóvenes científicos👨🏼‍🔬 Gracias a mis compañeros de Aspichueta Lab (Lipids & Liver) y en especial a Patricia Aspichueta La ciencia avanza en grupo 🤲🏼

Felicidades a Fran!! Muy merecido por todo el esfuerzo realizado! Estamos muy orgullosos de ti! @ehuscientia IIS Biocruces Bizkaia ahora IIS Biobizkaia gracias a las SEBBM y FEBS Letters por promover estos premios!

Congratulations!!

Un estudio de la UPV/EHU propone dianas terapéuticas para evitar el avance del hígado graso no alcohólico y el desarrollo de cáncer hepático asociado, con la inhibición de las proteínas E2F1 y E2F2. Aspichueta Lab (Lipids & Liver) @ehuscientia #EHUikerketa #EHUadituak ehu.eus/eu/-/gibel-gan…

🏆🏅We congratulate Francisco González-Romero Fran Aspichueta Lab (Lipids & Liver) UPV/EHU, on winning the FEBS Letters #posterprize at #SEBBM21! Patricia Aspichueta SEBBM SEBBM Barcelona 2021

📢Juan de la Cierva Postdoctoral position available! We are looking for candidates 🧑🏼‍🔬 to join our Lipids&Liver Research group at UPV/EHU to work in the exciting field of METABOLISM in LIVER DISEASES 🐭 📧Contact: [email protected] More info:aei.gob.es/convocatorias/…

Glad to share our just published paper in Nature Communications!! 🔹 We found that targeting Mat1a activates the liver-BAT axis by increasing NRF2-mediated FGF21 secretion, which prevents obesity, insulin resistance and hepatosteatosis Read more 👇🏼nature.com/articles/s4146…

💫Out in The Lancet Oncology ➡️ The #BiliaryCancers BABEL project from the EURO-CHOLANGIO-NET as part of the ENS-CCA lead by chiara braconi 📢Leaflets for chemotherapy were made available in 32 languages covering 208 countries Full paper 👇👇👇👇👇👇 thelancet.com/journals/lanon…

Yesterday Fran did a wonderful defense of a PhD, really proud of him! And thank you to the committee for a great discussion and all the ideas! Matxus Perugorria Javier Cubero Rocío IR Macías